Evidence map›Paper›PMID 36342525›Full record

ReviewZeitschrift fur Rheumatologie2023

[National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic DMARDS (disease modifying antirheumatic drugs)].

Eva Rath, Michael Bonelli, Christina Duftner, Johann Gruber, Peter Mandl, Florentine Moazedi-Furst, Herwig Pieringer, Rudolf Puchner, Holger Flick, Helmut J F Salzer and 7 more

Abstract readEnglish AbstractReviewConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Review in Zeitschrift fur Rheumatologie, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Eva RathÖsterreichische Gesellschaft für Rheumatologie und Rehabilitation (ÖGR), Wien, Österreich.
Michael BonelliÖsterreichische Gesellschaft für Rheumatologie und Rehabilitation (ÖGR), Wien, Österreich.
Christina DuftnerÖsterreichische Gesellschaft für Rheumatologie und Rehabilitation (ÖGR), Wien, Österreich.
Johann GruberÖsterreichische Gesellschaft für Rheumatologie und Rehabilitation (ÖGR), Wien, Österreich.
Peter MandlÖsterreichische Gesellschaft für Rheumatologie und Rehabilitation (ÖGR), Wien, Österreich.
Florentine Moazedi-FurstÖsterreichische Gesellschaft für Rheumatologie und Rehabilitation (ÖGR), Wien, Österreich.
Herwig PieringerÖsterreichische Gesellschaft für Rheumatologie und Rehabilitation (ÖGR), Wien, Österreich.
Rudolf PuchnerÖsterreichische Gesellschaft für Rheumatologie und Rehabilitation (ÖGR), Wien, Österreich.
Holger FlickÖsterreichische Gesellschaft für Pulmologie (ÖGP), Wien, Österreich.
Helmut J F SalzerÖsterreichische Gesellschaft für Pulmologie (ÖGP), Wien, Österreich.
Günter WeissÖsterreichische Gesellschaft für Rheumatologie und Rehabilitation (ÖGR), Wien, Österreich.
Stefan WinklerÖsterreichische Gesellschaft für Infektionskrankheiten und Tropenmedizin (ÖGIT), Kottingbrunn, Österreich.
Hans SkvaraÖsterreichische Gesellschaft für Dermatologie und Venerologie (ÖGDV), Wien, Österreich.
Alexander MoschenÖsterreichische Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH), Wien, Österreich.
Harald HoferÖsterreichische Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH), Wien, Österreich.
Julia FeursteinÖsterreichische Gesellschaft für Rheumatologie und Rehabilitation (ÖGR), Wien, Österreich.
Judith SautnerÖsterreichische Gesellschaft für Rheumatologie und Rehabilitation (ÖGR), Wien, Österreich. judith.sautner@meduniwien.ac.at.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This nationwide Austrian consensus statement summarizes the recommendations on the management of latent tuberculosis by treatment with biologic and targeted synthetic DMARDs. The essential questions with respect to screening and preventive treatment were discussed by experts from the disciplines of rheumatology, pneumology, infectious diseases, dermatology and gastroenterology, based on the available data, and then a joint consensus was formed by agreement. This involved a differentiated discussion on the various forms of treatment, and clear recommendations were formulated.

Indexed as

Antirheumatic AgentsArthritis, RheumatoidBiological ProductsDermatologyGastroenterologyLatent TuberculosisPulmonary MedicineRheumatologyAustriaHumansAntirheumatic AgentsBiological ProductsDrugsPreventive treatmentRecommendationsRisk reductionScreening

Identifiers

PMID36342525
PMCPMC9981509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.